Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Assessment of the Safety and Performance of the Modulus® 3D-printed Titanium Interbody Implant in Patients Undergoing eXtreme Lateral Interbody Fusion (XLIF®)

NCT04418817 is registered in ClinicalTrials.gov with NuVasive as lead sponsor.

NCT NCT04418817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04418817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Assessment of the Safety and Performance of the Modulus® 3D-printed Titanium Interbody Implant in Patients Undergoing eXtreme Lateral Interbody Fusion (XLIF®)
Lead sponsor
NuVasive
Phase
Observational
Overall status
Completed
Start date
March 22, 2020
Completion date
January 31, 2024
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease, degenerative scoliosis, degenerative spondylolisthesis